4.6 Article

Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Multiple early factors anticipate post-acute COVID-19 sequelae

Yapeng Su et al.

Summary: Post-acute sequelae of COVID-19 (PASC) is an emerging global crisis, and the quantifiable risk factors and biological associations are not well understood. In this study, a deep multi-omic investigation was conducted on 309 COVID-19 patients, and four PASC-anticipating risk factors were identified at the time of initial diagnosis. The study also observed changes in immune states during recovery from COVID-19.
Article Respiratory System

European Respiratory Society statement on long COVID follow-up

Katerina M. Antoniou et al.

Summary: This study summarizes the characteristics and impacts of follow-up care for long COVID patients in the 1-6 month period and finds limited evidence.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Immunology

Lung Function Decline in Relation to COVID-19 in the General Population: A Matched Cohort Study With Prepandemic Assessment of Lung Function

Katrine K. Iversen et al.

Summary: In nonhospitalized individuals, the decline in lung function related to COVID-19 was small but measurable, comparable to the minimal clinically important differences for FEV(1) and FVC that have been published.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Virology

Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission

Ignacio Perez Catalan et al.

Summary: This study analyzed the long-term symptoms of COVID-19 patients and found that treatment with corticosteroids during the acute phase may attenuate the presence of long-term symptoms and improve patients' quality of life.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Critical Care Medicine

Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

Guillaume Eberst et al.

Summary: This study aimed to evaluate the long-term pulmonary and extrapulmonary function of SARS-CoV-2 pneumonia survivors who stayed in the ICU for 12 months. The results showed that most patients had an improvement in DLCO at each timepoint.

ANNALS OF INTENSIVE CARE (2022)

Article Critical Care Medicine

Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study

Lixue Huang et al.

Summary: With the ongoing COVID-19 pandemic, a study was conducted to characterize the longitudinal evolution of health outcomes in hospitalized survivors of COVID-19 over a period of 2 years. The study found that although most survivors recovered and returned to work within 2 years, a significant proportion of them experienced persistent symptoms and health problems. These findings emphasize the need for further research and interventions to understand and reduce the risk of long-term COVID-19.

LANCET RESPIRATORY MEDICINE (2022)

Article Respiratory System

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge

Natalie Lorent et al.

Summary: COVID-19 survivors experienced limitations at 3 months, but showed improvement to almost complete recovery at 1 year. Factors such as female sex, pre-existing lung disease, smoking, and disease severity were related to poor functional recovery.

ERJ OPEN RESEARCH (2022)

Article Medicine, General & Internal

Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months

Mu Chen et al.

Summary: This study identified that the first three months after discharge are critical for the recovery of diffusion capacity in COVID-19 survivors. Impaired diffusion capacity was more severe and recovered slower in females, and was associated with a peak total lesion score of chest CT > 8.5. Early pulmonary rehabilitation and personalized interventions may be important for recovery in these patients.

ECLINICALMEDICINE (2022)

Article Rheumatology

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Anna-Maria Hoffmann-Vold et al.

Summary: This study utilized data from the European Scleroderma Trials And Research (EUSTAR) database to analyze the disease course, progression patterns, and predictive factors for progressive interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD (SSc-ILD). The results showed that male sex, higher modified Rodnan skin score, and reflux/dysphagia symptoms were the strongest predictive factors for forced vital capacity (FVC) decline over a 5-year period in SSc-ILD patients.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Respiratory System

Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life

Fabio Anastasio et al.

Summary: This study evaluated the mid-term clinical impact of COVID-19 on respiratory function in 379 patients, finding that lung damage during acute infection correlates with the reduction in pulmonary function.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Medicine, General & Internal

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Luc Morin et al.

Summary: After 4 months of hospitalization for COVID-19, a significant proportion of patients reported new symptoms and abnormalities in lung scans were common. Further research is needed to understand the long-term consequences of COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Critical Care Medicine

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Xiaojun Wu et al.

Summary: Most patients recovering from severe COVID-19 showed improvement in dyspnoea scores and exercise capacity over time, but a subgroup of patients still exhibited persistent physiological and radiographic changes at 12 months post-discharge. A unified pathway for respiratory follow-up is needed for COVID-19 patients.

LANCET RESPIRATORY MEDICINE (2021)

Article Medicine, General & Internal

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

Lixue Huang et al.

LANCET (2021)

Article Respiratory System

Residual respiratory impairment after COVID-19 pneumonia

Francesco Lombardi et al.

Summary: Approximately one month after hospital discharge, patients recovering from COVID-19 may experience residual respiratory impairment, including decreased exercise tolerance. The extent of impairment appears to be related to the severity of respiratory failure during hospitalization.

BMC PULMONARY MEDICINE (2021)

Editorial Material Respiratory System

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Xiaoneng Mo et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Respiratory System

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection

Justine Frija-Masson et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Critical Care Medicine

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

Eddy Fan et al.

LANCET RESPIRATORY MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

Autopsy of COVID-19 patients in China

Xiu-Wu Bian

NATIONAL SCIENCE REVIEW (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Respiratory System

Respiratory follow-up of patients with COVID-19 pneumonia

Peter M. George et al.

THORAX (2020)

Review Respiratory System

Interpretative strategies for lung function tests

R Pellegrino et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Respiratory System

Standardisation of spirometry

MR Miller et al.

EUROPEAN RESPIRATORY JOURNAL (2005)